[Pathogenetic basis for treating and preventing transient cerebral circulatory disorders (review)].
D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001158:Arteries; D001161:Arteriosclerosis / Q000150:complications / Q000601:surgery; D001494:Baths; D006294:Health Resorts; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000628:therapy; D002537:Intracranial Arteriosclerosis / Q000150:complications; D002542:Intracranial Embolism and Thrombosis / Q000150:complications; D002546:Ischemic Attack, Transient / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D012306:Risk; D013035:Spasm / Q000150:complications; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D000959:Antihypertensive Agents; D014665:Vasodilator Agents
Patogeneticheskie osnovy lecheniia i profilaktiki prekhodiashchikh narusheniĭ mozgovogo krovoobrashcheniia